secwatch.observer — SEC 8-K summary
======================================

Issuer:     Forte Biosciences, Inc. (FBRX)
CIK:        0001419041
Form:       8-K/A
Filed at:   2024-02-16T23:59:59+00:00
Accession:  0001193125-24-038496
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Forte Biosciences board sets advisory vote on executive pay every three years
-----------------------------------------------------------------------------

- Stockholders at Sept. 19, 2023 annual meeting cast highest votes for annual say-on-pay, second highest for triennial.
- Board decided to hold advisory vote on executive compensation every three years, citing longer-term focus.
- Next vote on frequency of say-on-pay will occur no later than 2029.
- 41.3% of votes favored triennial frequency; board considered equity vesting and strategic long-term decisions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419041/000119312524038496/0001193125-24-038496-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419041/000119312524038496/d747778d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-038496

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer